SMAD4 and pancreatic adenocarcinoma: In addition, based on data from colorectal and pancreatic adenocarcinoma cell lines, it has been shown that S100A9 is preponderant in the promotion of tumor growth in SMAD4-negative cancer cells [154] supporting a link between S100A9/TGF-β/SMAD4.